- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07640243
Sedation Methods in Percutaneous Transhepatic Biliary Drainage: Procedure Quality and Recovery
Evaluation of Sedation Methods Used in Percutaneous Transhepatic Biliary Drainage Procedures in Terms of Procedure Quality, Recovery Time, and Side Effects
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Percutaneous transhepatic biliary drainage (PTBD) is a therapeutic procedure commonly performed in patients with biliary obstruction when surgical intervention or endoscopic retrograde cholangiopancreatography is not feasible. These patients frequently present with advanced age, malignancy, cholangitis, and significant comorbidities, making them particularly vulnerable to sedation-related complications.
Procedural sedation and analgesia are commonly used during interventional radiology procedures to ensure patient comfort, immobility, and procedural success. However, inadequate sedation may result in patient movement, increased anxiety, procedural failure, and complications, whereas excessive sedation may lead to hemodynamic instability, respiratory depression, and delayed recovery, especially in frail patients.
In this study, two commonly used sedation regimens-propofol combined with remifentanil and propofol combined with ketamine-will be compared. Both regimens are routinely used in non-operating room anesthesia settings in our institution. Patients will be randomly assigned in a 1:1 ratio to one of the two groups. Standard monitoring will be applied, including non-invasive blood pressure, electrocardiography, and pulse oximetry, with supplemental oxygen administered via nasal cannula.
Sedation depth will be targeted to a Ramsay Sedation Score of 3-4 and assessed every five minutes during the procedure. Hemodynamic parameters, oxygen saturation, pain scores, recovery time, and adverse events such as hypotension, bradycardia, hypoxia, nausea, vomiting, and airway interventions will be recorded. Recovery will be evaluated using the Modified Aldrete Score at two-minute intervals until adequate recovery is achieved.
The primary objective of the study is to compare recovery times between the two sedation regimens. Secondary objectives include comparison of pain intensity, patient and operator satisfaction, total drug consumption, procedural tolerance, and incidence of adverse events. The findings of this study aim to contribute to safer and more effective sedation strategies for PTBD procedures in high-risk patient populations.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Ankara
-
Ankara, Ankara, Turkije (Türkiye), 06800
- Werving
- Ankara Bilkent City Hospital
-
Contact:
- Mücahid MD Mutlu, Resident
- Telefoonnummer: +905078260298
- E-mail: mucahid.mutlu@gmail.com
-
Contact:
- Mücahid Mutlu
- Telefoonnummer: +905078260298
- E-mail: mucahid.mutlu@gmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Scheduled for elective percutaneous transhepatic biliary drainage (PTBD) and/or biliary stenting
- ASA physical status II-IV
- Fasting time of at least 6 hours prior to the procedure
- Ability to provide written informed consent
Exclusion Criteria:
- Inability to provide informed consent or to complete study assessments (e.g., Ramsay Sedation Scale, FRAIL scale, Numeric Rating Scale)
- Clinical diagnosis of Alzheimer's Disease
- Clinical diagnosis of demantia
- Known allergy or hypersensitivity to propofol, remifentanil, ketamine, ondansetron, or deksketoprofen
- Grade 3-4 aortic, mitral, or tricuspid valve disease
- Advanced or decompensated heart failure (ejection fraction <25%)
- Emergency procedures
- Refusal to participate in the study
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Propofol-Remifentanil
Participants received intravenous propofol 0.5 mg/kg followed by a continuous intravenous remifentanil infusion initiated at 0.10-0.18
mcg/kg/min during the procedure.
The remifentanil infusion rate was adjusted within the specified range according to clinical response to maintain adequate sedation, analgesia, and hemodynamic stability throughout the procedure.
|
Intravenous propofol combined with remifentanil infusion for procedural sedation during percutaneous transhepatic biliary drainage.
|
|
Experimenteel: Propofol-Ketamine
IParticipants received intravenous propofol 0.5 mg/kg followed by intravenous ketamine 0.3 mg/kg.
Additional intravenous ketamine 5 mg was administered every 5 minutes as needed during the procedure to maintain the target sedation level and hemodynamic stability.
|
Intravenous propofol combined with ketamine bolus for procedural sedation during percutaneous transhepatic biliary drainage.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Recovery Time
Tijdsspanne: From completion of the procedure until Modified Aldrete Score >8, assessed up to 30 minutes
|
Time to achieve adequate recovery assessed using the Modified Aldrete Score.
|
From completion of the procedure until Modified Aldrete Score >8, assessed up to 30 minutes
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Hemodynamic Stability
Tijdsspanne: Baseline, every 5 minutes during the procedure (assessed up to 60 minutes), and immediately after the procedure.
|
Changes in systolic, diastolic, and mean arterial blood pressure, heart rate, and oxygen saturation during the procedure.
|
Baseline, every 5 minutes during the procedure (assessed up to 60 minutes), and immediately after the procedure.
|
|
Pain Intensity
Tijdsspanne: Baseline (pre-procedure), immediately after recovery, and at 30 minutes post-recovery.
|
Pain intensity assessed using the Numeric Rating Scale (NRS)
|
Baseline (pre-procedure), immediately after recovery, and at 30 minutes post-recovery.
|
|
Sedation Depth
Tijdsspanne: Every 5 minutes during the procedure, assessed up to 30 minutes.
|
Sedation level assessed using the Ramsay Sedation Scale.
|
Every 5 minutes during the procedure, assessed up to 30 minutes.
|
|
Adverse Events
Tijdsspanne: Perioperatively and through the recovery period, assessed up to 30 minutes.
|
Incidence of sedation-related adverse events including hypotension, bradycardia, hypoxia, apnea, nausea, and vomiting.
|
Perioperatively and through the recovery period, assessed up to 30 minutes.
|
|
Patient and Operator Satisfaction
Tijdsspanne: Immediately after the procedure
|
Patient and operator satisfaction assessed after completion of the procedure.
|
Immediately after the procedure
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Ziekten van het spijsverteringsstelsel
- Ziekten van de galwegen
- Galwegaandoeningen
- Neoplasmata
- Cholangitis
- Organische chemicaliën
- Heterocyclische verbindingen, 1-ring
- Heterocyclische verbindingen
- Koolwaterstoffen
- Cyclohexanes
- Cycloparaffins
- Koolwaterstoffen, alicyclisch
- Koolwaterstoffen, cyclisch
- Zuren, acyclisch
- Carbonzuren
- Piperidines
- Propionaten
- Remifentanil
- Ketamine
Andere studie-ID-nummers
- TABED-1-25-1188
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Cholangitis
-
RenJi HospitalWervingPrimaire scleroserende cholangitis | IgG4-gerelateerde scleroserende cholangitisChina
-
Brigham and Women's HospitalVoltooidScleroserende cholangitisVerenigde Staten
-
Mayo ClinicVoltooidPrimaire scleroserende cholangitis (PSC)Verenigde Staten
-
Medical University of WarsawNational Science Centre, PolandActief, niet wervendPrimaire scleroserende cholangitis (PSC)Polen
-
Cascade Pharmaceuticals, IncCovanceVoltooidPrimaire scleroserende cholangitis (PSC)Verenigde Staten
-
IpsenWervingPrimaire scleroserende cholangitisVerenigde Staten
-
HighTide Biopharma Pty LtdVoltooidPrimaire scleroserende cholangitis (PSC)Verenigde Staten, Canada
-
Intercept PharmaceuticalsVoltooidPrimaire scleroserende cholangitis (PSC)Verenigde Staten, Italië
-
Mirum Pharmaceuticals, Inc.VoltooidPrimaire scleroserende cholangitis (PSC)Verenigde Staten, Verenigd Koninkrijk, Canada
-
Mayo ClinicVoltooidPrimaire scleroserende cholangitis (PSC)Verenigde Staten
Klinische onderzoeken op Remifentanil
-
University Medical Center GroningenVoltooidAnesthesie | Hemodynamische instabiliteit | Interactie | Stoornis van zuurstoftransportNederland
-
Inje UniversityVoltooidScheelzienKorea, republiek van
-
Ciusss de L'Est de l'Île de MontréalVoltooidIntubatie; Moeilijk of misluktCanada
-
Helse FonnaVoltooidAnesthesie, generaal | Anesthesie, intraveneus | Hemodynamische instabiliteitNoorwegen
-
University of ChileWervingAnesthesie, intraveneus | Elektro-encefalografie | Burst-onderdrukkingChili
-
Seoul National University HospitalAjou University School of Medicine; Severance HospitalVoltooidZuigeling, PrematuurKorea, republiek van
-
Centre Hospitalier Universitaire de NīmesVoltooid
-
Hopital FochVoltooid
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalWervingPercutane nefrolithotomie | Transurethrale resectie van de blaas | Transurethrale resectie van de prostaat | Ureterorenoscopische lithotripsieTurkije (Türkiye)
-
Zhang HaopengVoltooid